GranzieraCWuerfelJBarkhofF, et al. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain2021; 144: 1296–1311.
2.
MühlauM. T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis: No. Mult Scler2021.
3.
NakamuraKZhengYOntanedaD. T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis: Yes. Mult Scler2021.
4.
RighartRBiberacherVJonkmanLE, et al. Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging. Ann Neurol2017; 82(4): 519–529.
5.
PreziosaPBoumanPMKiljanS, et al. Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis. J Neurol Neurosurg Psychiatry2021; 92(7): 790–792.
6.
ParetoDGarcia-VidalAAlberichM, et al. Ratio of T1-weighted to T2-weighted signal intensity as a measure of tissue integrity. AJNR Am J Neuroradiol2020; 41(3): 461–463.
7.
ZhengYDudmanJChenJT, et al. Sensitivity of T1/T2-weighted ratio in detection of cortical demyelination is similar to magnetization transfer ratio using post-mortem MRI. Mult Scler. Epub ahead of print 20May2021. DOI: 10.1177/13524585211014760.
8.
ShamsZNorrisDGMarquesJP. A comparison of in vivo MRI based cortical myelin mapping using T1w/T2w and R1 mapping at 3T. PLoS ONE2019; 14(7): e0218089.
9.
PreziosaPStorelliLMeaniA, et al. Effects of fingolimod and natalizumab on brain T1-/T2-weighted and magnetization transfer ratios: A 2-year study. Neurotherapeutics2021; 18(2): 878–888.
